Literature DB >> 30797417

Characteristics of the traditional Liu-Wei-Di-Huang prescription reassessed in modern pharmacology.

Xiao-Rui Cheng1, Chun-Hui Qi2, Tong-Xing Wang1, Wen-Xia Zhou3, Yong-Xiang Zhang4.   

Abstract

Liu-Wei-Di-Huang (LW) is a Yin nourishing and kidney tonifying prescription in traditional Chinese medicine with promising pharmacological characteristics that can be further exploited and developed in modern medicine. We provide a comprehensive and detailed literature report on the clinical and experimental pharmacology of LW, including its quality control parameters, phytochemistry, pharmacokinetics, and toxicology. Our literature review indicates that the LW prescription possesses a unique combination of pharmacological characteristics that can be safely used for treating very different diseases. Quality control and pharmacokinetic parameters of LW are mostly based on its major bioactive phytochemical constituents. We postulate that modulating or rebalancing the neuroendocrine immunomodulation network in the body is the underlying mechanism of the multiple pharmacological activities displayed by LW.
Copyright © 2019 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Keywords:  Liu-Wei-Di-Huang; Pharmacokinetics; Pharmacology; Phytochemistry; Toxicology; Traditional Chinese medicine

Mesh:

Substances:

Year:  2019        PMID: 30797417     DOI: 10.1016/S1875-5364(19)30013-5

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  4 in total

1.  Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis.

Authors:  Zhaoqi Lu; Minling Huang; Haixiong Lin; Gaoxiang Wang; Huilin Li
Journal:  J Orthop Surg Res       Date:  2022-06-14       Impact factor: 2.677

2.  Bioinformatics-Based Approach for Exploring the Immune Cell Infiltration Patterns in Alzheimer's Disease and Determining the Intervention Mechanism of Liuwei Dihuang Pill.

Authors:  Chenling Zhao; Zhangsheng Jiang; Liwei Tian; Lulu Tang; An Zhou; Ting Dong
Journal:  Dose Response       Date:  2022-07-21       Impact factor: 2.623

3.  Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion.

Authors:  Xiaodong Zhu; Xiaogang Shen; Bo Lin; Jiaxi Fang; Juan Jin; Qiang He
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

4.  Determining novel candidate anti-hepatocellular carcinoma drugs using interaction networks and molecular docking between drug targets and natural compounds of SiNiSan.

Authors:  Qin Zhang; Zhangying Feng; Mengxi Gao; Liru Guo
Journal:  PeerJ       Date:  2021-02-16       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.